πŸ‡ΊπŸ‡Έ FDA
Patent

US 10287564

Procoagulant compounds

granted A61KA61K38/02A61K38/36

Quick answer

US patent 10287564 (Procoagulant compounds) held by BIOVERATIV THERAPEUTICS INC. expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/02, A61K38/36, A61K38/4846, A61P